Drug Patent Expirations for September 2014

Drug Patent Expirations for September 2014

Tradename	Applicant	Generic Name	Patent No.
COMBIVENT RESPIMAT	Boehringer Ingelheim	albuterol sulfate; ipratropium bromide	5,662,271
HEPSERA	Gilead	adefovir dipivoxil	5,663,159
BONIVA	Roche	ibandronate sodium	5,662,918
MOXEZA	Alcon Pharms Ltd	moxifloxacin hydrochloride	5,607,942*PED
VIGAMOX	Alcon Pharms Ltd	moxifloxacin hydrochloride	5,607,942*PED
ALINIA	Romark	nitazoxanide	5,578,621
ALINIA	Romark	nitazoxanide	6,020,353
PROTOPIC	Astellas	tacrolimus	5,665,727
RENVELA	Genzyme	sevelamer carbonate	5,667,775
RENAGEL	Genzyme	sevelamer hydrochloride	5,667,775
EXUBERA	Pfizer	insulin recombinant human	6,543,448
NAROPIN	Fresenius Kabi Usa	ropivacaine hydrochloride	5,670,524
ATRALIN	Dow Pharm	tretinoin	5,670,547
NEORAL	Novartis	cyclosporine	5,985,321
IONSYS	Incline Therap	fentanyl hydrochloride	7,027,859
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.